Show Search Form
registered interest | ![]() |
![]() |
||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | ![]() ![]() ![]() |
|||||||||||||||||||||||||||||||||
answering body |
|
|||||||||||||||||||||||||||||||||
answering dept id | 208 | ![]() |
||||||||||||||||||||||||||||||||
answering dept short name | Foreign, Commonwealth and Development Office | ![]() |
||||||||||||||||||||||||||||||||
answering dept sort name | Foreign, Commonwealth and Development Office | ![]() |
||||||||||||||||||||||||||||||||
hansard heading | Malaria: Drugs | ![]() |
||||||||||||||||||||||||||||||||
house id | 1 | ![]() |
||||||||||||||||||||||||||||||||
legislature |
|
|||||||||||||||||||||||||||||||||
question text | To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether he has received representations on the potential role of anti-body drugs in tackling malaria. | ![]() |
||||||||||||||||||||||||||||||||
tabling member constituency | Strangford | ![]() |
||||||||||||||||||||||||||||||||
tabling member printed |
|
|||||||||||||||||||||||||||||||||
uin | 53898 | ![]() |
||||||||||||||||||||||||||||||||
answer |
|
|||||||||||||||||||||||||||||||||
tabling member |
|
registered interest | ![]() |
![]() |
|||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | ![]() ![]() ![]() |
||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 11 | ![]() |
|||||||||||||||||||||||||||||
answering dept short name | Defence | ![]() |
|||||||||||||||||||||||||||||
answering dept sort name | Defence | ![]() |
|||||||||||||||||||||||||||||
hansard heading | Malaria: Drugs | ![]() |
|||||||||||||||||||||||||||||
house id | 2 | ![]() |
|||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty's Government whether the health and wellbeing of all participants in the Surgeon-General’s 2016–17 research study on anti-malarial chemoprophylaxis (Ref: 713/MoDREC/15) was monitored to ensure that all adverse events occurring during the study were reported to the Medicines and Healthcare products Regulatory Agency (MHRA); whether participants have been monitored following the study to ensure that any adverse events that have occurred since are being reported to the MHRA; and what assessment they have made of whether suitable treatment is available to those participants suffering adverse events. | ![]() |
|||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL16837 | ![]() |
|||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|